Mylan Is To Provide India With HIV Drugs On Lower Price

Mylan will provide India with Avonza, an antiretroviral drug, recommended by the WHO as an alternative first-line regimen for people living with HIV. The drug will be realised in India at lower cost than in the other countries, Mylan provided the medicines. The president of the company said Mylan is to be the first to offer this drug in India.

The drug price still remains unknown as well as how much cheaper it will be than other first-line ARVs. Mylan company provide more than half of the patients with HIV positive status in nearly 100 countries, as was stated in the company’s release.

Around 210 thousand people are estimated to be living with HIV in India but only 14 lakh are known cases, according to the health ministry.